Hiroto Ohguchi is an associate professor at Institute of Resource Development and Analysis, Kumamoto University. He received his MD in 2000 from Tohoku University School of Medicine, Japan, and trained in hematology at Tohoku University Hospital. He then received his PhD in 2007 from Tohoku University Graduate School of Medicine. In 2011, he joined the laboratory of Dr. Kenneth Anderson at Dana-Farber Cancer Institute and worked as an instructor from 2016. He has joined Kumamoto University from 2018. He has a long-standing interest in pathophysiology of hematological malignancies, especially multiple myeloma, and his research focuses on the epigenetic and transcriptional regulation of multiple myeloma cells.
Hiroto Ohguchi is an associate professor at Institute of Resource Development and Analysis, Kumamoto University. He received his MD in 2000 from Tohoku University School of Medicine, Japan, and trained in hematology at Tohoku University Hospital. He then received his PhD in 2007 from Tohoku University Graduate School of Medicine. In 2011, he joined the laboratory of Dr. Kenneth Anderson at Dana-Farber Cancer Institute and worked as an instructor from 2016. He has joined Kumamoto University from 2018. He has a long-standing interest in pathophysiology of hematological malignancies, especially multiple myeloma, and his research focuses on the epigenetic and transcriptional regulation of multiple myeloma cells.